Nvwm, LLC Crispr Therapeutics Ag Transaction History

Nvwm, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$43.23 - $73.83 $489,450 - $835,903	-11,322 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$53.19 - $79.24 $10,052 - $14,976	-189 Reduced 1.64%	11,322 $710,000
Q3 2021 Nov 03, 2021	BUY	$110.2 - $156.64 $9,146 - $13,001	83 Added 0.73%	11,511 $1.29 Million
Q2 2021 Aug 04, 2021	BUY	$100.84 - $161.89 $32,369 - $51,966	321 Added 2.89%	11,428 $1.85 Million
Q1 2021 May 11, 2021	SELL	$110.72 - $210.04 $7,307 - $13,862	-66 Reduced 0.59%	11,107 $1.35 Million
Q4 2020 Feb 09, 2021	BUY	$79.67 - $173.23 $19,280 - $41,921	242 Added 2.21%	11,173 $1.71 Million
Q3 2020 Dec 10, 2020	BUY	$78.5 - $100.64 $13,502 - $17,310	172 Added 1.6%	10,931 $915,000
Q1 2020 May 08, 2020	BUY	$33.68 - $62.53 $27,112 - $50,336	805 Added 8.09%	10,759 $456,000
Q4 2019 Feb 07, 2020	SELL	$36.68 - $73.13 $12,067 - $24,059	-329 Reduced 3.2%	9,954 $606,000
Q3 2019 Oct 29, 2019	BUY	$40.99 - $52.56 $421,500 - $540,474	10,283 New	10,283 $422,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.